108 results
Page 3 of 6
8-K
EX-99.1
coi7xghp
9 May 22
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
4:20pm
POS AM
gvqlpk882
1 Mar 22
Prospectus update (post-effective amendment)
6:38pm
S-8
9li6u7 mt0
1 Mar 22
Registration of securities for employees
6:32pm
S-8
j8y6a8i0uhn
1 Mar 22
Registration of securities for employees
6:32pm
POSASR
42k1l1nuac0qgtjouuzp
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:01pm
POSASR
977hcz2 tmyuwkh
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:01pm
8-K
EX-99.1
8y9 qq3zmlsfi
10 Jan 22
Regulation FD Disclosure
6:40am
S-3ASR
0fyzwjrl
16 Aug 21
Automatic shelf registration
5:19pm
S-3ASR
EX-4.4
hoftu5ri28ly0y7ah8qo
16 Aug 21
Automatic shelf registration
5:19pm
10-K
lt9850o
25 Mar 21
Annual report
7:16am
S-8
pn5lzsdu
25 Mar 21
Registration of securities for employees
12:00am
8-K
EX-10.1
a36vlmz3q6utz wc0hc4
22 Dec 20
Entry into a Material Definitive Agreement
4:05pm
10-Q
37ldt lt1
8 Sep 20
Quarterly report
5:18pm
8-K
EX-3.2
6h6kg80dw71gpo
28 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-3.1
gpl151gurbz
28 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:21pm
S-8
ywx 1ncw5
24 Jul 20
Registration of securities for employees
5:31pm